289 related articles for article (PubMed ID: 21055622)
1. Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease.
Liu Y; Zhu L; Plössl K; Choi SR; Qiao H; Sun X; Li S; Zha Z; Kung HF
Nucl Med Biol; 2010 Nov; 37(8):917-25. PubMed ID: 21055622
[TBL] [Abstract][Full Text] [Related]
2. An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2.
Zhu L; Liu Y; Plössl K; Lieberman B; Liu J; Kung HF
Nucl Med Biol; 2010 Feb; 37(2):133-41. PubMed ID: 20152712
[TBL] [Abstract][Full Text] [Related]
3. Optimization of solid-phase extraction (SPE) in the preparation of [
Yao X; Zha Z; Zhao R; Choi SR; Ploessl K; Liu F; Zhu L; Kung HF
Nucl Med Biol; 2019 Apr; 71():54-64. PubMed ID: 31152974
[TBL] [Abstract][Full Text] [Related]
4. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
5. An improved preparation of [
Zhang L; Zhang A; Yao X; Zhang Y; Liu F; Hong H; Zha Z; Liu Y; Wu Z; Qiao J; Zhu L; Kung HF
J Labelled Comp Radiopharm; 2020 Mar; 63(3):108-118. PubMed ID: 31697847
[TBL] [Abstract][Full Text] [Related]
6. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF
J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759
[TBL] [Abstract][Full Text] [Related]
7. GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain.
Yao CH; Lin KJ; Weng CC; Hsiao IT; Ting YS; Yen TC; Jan TR; Skovronsky D; Kung MP; Wey SP
Appl Radiat Isot; 2010 Dec; 68(12):2293-7. PubMed ID: 20638295
[TBL] [Abstract][Full Text] [Related]
8. Preparation and stability of ethanol-free solution of [18F]florbetapir ([18F]AV-45) for positron emission tomography amyloid imaging.
Hayashi K; Tachibana A; Tazawa S; Mizukawa Y; Osaki K; Morimoto Y; Zochi R; Kurahashi M; Aki H; Takahashi K
J Labelled Comp Radiopharm; 2013 May; 56(5):295-300. PubMed ID: 24285374
[TBL] [Abstract][Full Text] [Related]
9. An automated radiosynthesis of (S)-[
Xie JK; Zhu XX; Wang KX; Wang SC; Xie Q
Appl Radiat Isot; 2021 Aug; 174():109740. PubMed ID: 33940354
[No Abstract] [Full Text] [Related]
10. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
11. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
[TBL] [Abstract][Full Text] [Related]
12. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.
Lin KJ; Hsu WC; Hsiao IT; Wey SP; Jin LW; Skovronsky D; Wai YY; Chang HP; Lo CW; Yao CH; Yen TC; Kung MP
Nucl Med Biol; 2010 May; 37(4):497-508. PubMed ID: 20447562
[TBL] [Abstract][Full Text] [Related]
13. Automated synthesis of [18F]Florbetaben as Alzheimer's disease imaging agent based on a synthesis module system.
Wang H; Guo X; Jiang S; Tang G
Appl Radiat Isot; 2013 Jan; 71(1):41-6. PubMed ID: 23085550
[TBL] [Abstract][Full Text] [Related]
14. [
Nguyen GAH; Liang C; Mukherjee J
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889425
[TBL] [Abstract][Full Text] [Related]
15. Simple Synthesis of [
Zhang QZ; Yilihamu N; Li YB; Li XH; Qin YD
Curr Med Chem; 2024; 31(10):1278-1288. PubMed ID: 37526186
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and preliminary evaluation of [
He Y; Zhu X; Wang K; Xie J; Zhu Z; Ni M; Wang S; Xie Q
Bioorg Med Chem; 2022 Dec; 75():117087. PubMed ID: 36356533
[TBL] [Abstract][Full Text] [Related]
17. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
Lister-James J; Pontecorvo MJ; Clark C; Joshi AD; Mintun MA; Zhang W; Lim N; Zhuang Z; Golding G; Choi SR; Benedum TE; Kennedy P; Hefti F; Carpenter AP; Kung HF; Skovronsky DM
Semin Nucl Med; 2011 Jul; 41(4):300-4. PubMed ID: 21624563
[TBL] [Abstract][Full Text] [Related]
18. VMAT2 imaging agent, D6-[
Zhao R; Zha Z; Yao X; Ploessl K; Choi SR; Liu F; Zhu L; Kung HF
Nucl Med Biol; 2019; 72-73():26-35. PubMed ID: 31330409
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB
J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119
[TBL] [Abstract][Full Text] [Related]
20. Facile and rapid one-step radiosynthesis of [(18)F]BAY94-9172 with a new precursor.
Wang H; Shi H; Yu H; Jiang S; Tang G
Nucl Med Biol; 2011 Jan; 38(1):121-7. PubMed ID: 21220135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
